More pharma products can be brought under quality improvement norms for export, says DGFT

"As per CDSCO's advice, whatever needs to be done for quality improvement in pharma will be done," DGFT said.

Published On 2023-05-24 06:06 GMT | Update On 2023-05-24 10:29 GMT

New Delhi: More pharmaceutical products can be brought under mandatory quality improvement norms if needed to comply with global standards for export from India if the health ministry issues an advice in this regard, a top official said on Tuesday. Director General Foreign Trade (DGFT) Santosh Kumar Sarangi said all pharmaceutical products must meet global standards and quality...

New Delhi: More pharmaceutical products can be brought under mandatory quality improvement norms if needed to comply with global standards for export from India if the health ministry issues an advice in this regard, a top official said on Tuesday. Director General Foreign Trade (DGFT) Santosh Kumar Sarangi said all pharmaceutical products must meet global standards and quality requirements.

His remarks come a day after the Directorate General of Foreign Trade in a notification said cough syrup exporters will have to undertake testing of their products at specified government laboratories from June 1 before getting permission for the outbound shipments.

The direction came in the wake of quality concerns raised globally for cough syrups exported by Indian firms.

"This is a continuous effort which has been started with cough syrup. It is our endeavour that any cough syrup exported from India must meet minimum benchmark requirement of quality standards. Therefore they will be exported after being tested in specified labs," Sarangi said at an event.

"As per CDSCO's (Central Drugs Standard Control Organisation) advice, whatever needs to be done for quality improvement in pharma will be done," he added.

Asked whether other pharmaceutical products will be brought under similar quality improvement norms for export from India, he said, as per CDSCO and the health ministry's advice, wherever there is a need of more stringent global benchmarking for pharma products, it will be done.

"The export of cough syrup shall be permitted to be exported subject to export samples being tested and production of certificate of analysis issued by any of the laboratories... with effect from June 1, 2023," the DGFT said in a notification on Monday.

The specified central government labs include Indian Pharmacopoeia Commission, regional drug testing lab (RDTL - Chandigarh), central drugs lab (CDL - Kolkata), central drug testing lab (CDTL - Chennai Hyderabad, Mumbai), RDTL (Guwahati), and NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited drug testing labs of state governments.

Read also: Exporters of cough syrup need to undertake product testing at govt labs from June 1

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

More pharma products can be brought under quality improvement norms for export, says DGFT

"As per CDSCO's advice, whatever needs to be done for quality improvement in pharma will be done," DGFT said.

Similar News